0 0 Chemicalname=Osimertinib Impurity A,Osimertinib Impurity A,CAS=CAS=1421373-98-9,Impurities of Osimertinib,reference standards of Osimertinib

Osimertinib Impurity A

IMPURITIES

Product Details

CAT No.# CS-AV-00079
Category Impurities
CAS 1421373-98-9
Molecular Weight 485.25
Molecular Formula C27H31N7O2
Purity: >98%
Synonyms: AZ 5104 ; Demethylated AZ9291. metabolite of AZD9291 ; N-(5-((4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide ; (AZD9291 Impurity A) Inhibitors; Osimertinib Metabolite M6
Application Notes: AZ 5104 is a derivative of AZD 9291 (A808075) is a selective EGFR inhibitor.
References: Finlay, M.R.V., et al.: J. Med. Chem., 57, 8249 (2014);
Shipping: Free Shipping for worldwide on order above 2000 USD
Osimertinib Impurity A Worldwide Suppliers of Osimertinib Impurity A Impurities Clearsynth CS-AV-00079

Product rating: 9 Osimertinib Impurity A based on 20 ratings

  1. Impurities
  2. Osimertinib Impurity A

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)


Smileys:
CN(CCN(C1=CC(OC)=C(NC2=NC=CC(C3=CNC4=CC=CC=C43)=N2)C=C1NC(C=C)=O)C)C



This page contains information about Osimertinib Impurity A Cas 1421373-98-9 and its Impurities.

Osimertinib Impurity A Osimertinib Impurity A Worldwide Suppliers of Osimertinib Impurity A Impurities Clearsynth 1421373-98-9

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."